776 abstracts found.



Results filter

Expression and distribution of cannabinoid receptors CB1 and CB2 in endometrial cancer

Year:

Session type:

Thangesweran Ayakannu1, Anthony Taylor1, Timothy Marczylo2, Jonathan Willets1, Quentin Davies3, Laurence Brown4, Esther Moss3, Justin Konje1
1Reproductive Sciences Section, Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, UK, 2Centre for Radiation, Chemical and Environtment Hazards, Public Health England, Harwell Campus, Oxfordshire, UK, 3University Hospitals of Leicester, NHS Trust, Gynaecology Oncology Department, Leicester, UK, 4University Hospitals of Leicester, NHS Trust, Pathology Department, Leicester, UK

Heterochromatin transcription and alternative chromosome end-protection mechanisms in the absence of canonical telomeres

Year:

Session type:

Martina Begnis1, Julie Cooper1
1Cancer Research UK London Research Institute, London, UK

Plasma endocannabinoids as potential biomarkers for endometrial cancer

Year:

Session type:

Thangesweran Ayakannu1, Anthony Taylor1, Timothy Marczylo2, Jonathan Willets1, Quentin Davies3, Laurence Brown4, Esther Moss3, Justin Konje1
1Reproductive Sciences Section, department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, UK, 2Centre for Radiation, Chemical and Environtment Hazards, Public Health England, Harwell Campus, Oxfordshire, UK, Oxfordshire, UK, 3University Hospitals of Leicester NHS Trust, Gynaecology Oncology Department, Leicester, UK, 4University Hospitals of Leicester NHS Trust, Pathology Department, Leicester, UK

It’s ok to ask – but who doesn’t get asked? Variations in research conversations with patients and potential participants

Year:

Session type:

Carolyn Morris1, Richard Stephens1, Matthew Baker1, Rachel Brannan2, Sheila Fisher3, Jane Hanson4, Karen Inns3, Sue Pavitt6, Karen Poole3, Reg Race7, Robert West6, Yoryos Lazaropoulos5
1NCRI Consumer Liaison Group, Leeds, UK, 2National Cancer Intelligence Network, London, UK, 3National Institute for Health Research Cancer Research Network, Leeds, UK, 4Sussex Cancer Research Network, Sussex, UK, 5School of Clinical Sciences University of Cambridge, Cambridge, UK, 6Leeds Institute of Health Sciences University of Leeds, Leeds, UK, 7Quality Health, Derbyshire, UK

The Breast Cancer after Radiotherapy Dataset (BARD): An initiative to improve screening for breast cancer in a cohort of high risk female lymphoma survivors in England

Year:

Session type:

John Radford1, Sacha Howell1, Catherine O'Hara2, Valerie Goode1, Kate Vaughan1, Simon Davies3, Richard Cowan1, Anthony Swerdlow4
1The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK, 2North West Public Health England, 3Teenage Cancer Trust, London, UK, 4Institute of Cancer Research, London, UK

Women’s narratives as an aid to decision making in breast reconstruction – development of a patient experience DVD

Year:

Session type:

Eilis McCaughan1, Stuart McIntosh2, Carrie Flanagan1, Adele Boyd3, John Winder3
1University of Ulster, Coleraine, UK, 2Belfast City Hospital, Belfast, UK, 3University of Ulster, Newtownabbey, UK

Feasibility of the CanTalk study, a randomised controlled trial to test the clinical and cost effectiveness of CBT plus treatment as usual for the treatment of depression in advanced cancer

Year:

Session type:

Marc Serfaty1, Deborah Haworth1, Stephen Pilling3, Irwin Nazareth3, Louise Jones2, Michael King1,3
1Mental Health Sciences Unit,University College London, London, UK, 2Marie Curie Palliative Care Research Unit, Mental Health Sciences Unit, University College London, London, UK, 3PRIMENT Clinical Trials Unit University College London, London, UK

Study protocol for “Moving Bright, Eating Smart” – A phase 2 clinical trial on the acceptabillity and feasibility of a diet and physical activity intervention to prevent recurrence in colorectal cancer survivors

Year:

Session type:

Judy Ho1,2, Antoinette Lee2, Duncan Macfarlane2, Daniel Fong2, Sharron Leung3, Ester Cerin2,4, Wynnie Chan2, Ivy Leung5, Sharon Lam2, Aliki Taylor6, Kar-keung Cheng6
1Queen Mary Hospital, Hong Kong, Hong Kong, 2The University of Hong Kong, Hong Kong, Hong Kong, 3Hong Kong Baptist Hospital, Hong Kong, Hong Kong, 4Deakin University, Victoria, Australia, 5Queen Elizabeth Hospital, Hong Kong, Hong Kong, 6The University of Birmingham, Birmingham, UK

“I have no wish to be at the tender mercies of a homophobic carer/service”: Exploring end of life experiences and care needs in the lives of older lesbian, gay, bisexual or trans  (LGBT) people.

Year:

Session type:

Anne Patterson1, Meiko Makita1, Kathryn Almack1
1University of Nottingham, Nottingham, UK

Use of androgen deprivation therapy and risk of fracture and osteoporosis amongst prostate cancer survivors: A systematic review and meta-analysis

Year:

Session type:

Nada Khan1, Robert Griffiths2
1University College London, London, UK, 2University of Oxford, Oxford, UK

Individually in fibroblast growth factor signalling pathways influences survival and identifies a novel drug resistance mechanism in ovarian cancer patients

Year:

Session type:

Lynne Sawers1, Michelle Ferguson1, Emma Joseph1, Bianca Ihrig1, Aparajitha Vaidyanathan1, Simon Herrington1, Charlie Gourley2, Roland Wolf1, Gillian Smith1
1Division of Cancer Research, Medical Research Institute, University of Dundee, Dundee, UK, 2Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK

RESTART: Rehabilitation Evaluation in Survivors of Testicular cancer After Radical Treatment: Pilot study effect on adjustment and psycho-social functioning

Year:

Session type:

Christopher Hewitt1, Jeff White1, Jamie Stobo1, Elaine McCartney1, Jennifer Harrington2, Sandra White3, Lesley Somerville1, Teresa Young4, Gordon Rustin4, Jim Paul1, Claire Lawless1
1Beatson West of Scotland Cancer Centre, Glasgow, UK, 2Li Ka Shing Cancer Centre, Cambridge, UK, 3NHS Ayrshire and Arran, Ayrshire, UK, 4Mount Vernon Cancer Centre, Middlesex, UK

Understanding and satisfaction in a cohort of West of Scotland cancer patients: A quantitative and qualitative survey in the Beatson Oncology Hospital

Year:

Session type:

Aishah Coyte1, Noelle O’Rourke2
1University of Glasgow Undergraduate Medical School, Glasgow, UK, 2West of Scotland Beatson Cancer Centre, Glasgow, UK

Detection of early radiation-induced heart disease

Year:

Session type:

Shahana Hussain1, Karen Bowman2, George Don Jones2, Rohan Machhar1, Ruth Barber1, Tim Gant3, George Tanteles2, Gerry McCann4, Chris Steadman4, Christopher Talbot1, Paul Symonds2, Nicola Royle1, Richard Camplejohn1, Julian Barwell1
1Department of Genetics, University of Leicester, Leicester, UK, 2Department of Cancer studies Molecular Medicine, University of Leicester, Leicester, UK, 3MRC Toxicology Unit, Leicester, UK, 4Department of Cardiovascular Sciences, University of Leicester, Leicester, UK

Patient education for those seeking peptide receptor radionuclide therapy

Year:

Session type:

Josh Mailman1
1NorCal CarciNET, Oakland, USA

Strong but not so silent. Experiences of providing a freephone number with apostal survey of prostate cancer survivors

Year:

Session type:

Frances Drummond2, Heather Kinnear1, Audrey Craven-Lynn1, Anna Gavin1, Linda Sharp2
1Queen's University Belfast, Belfast, UK, 2National Cancer Registry Ireland, Cork, Ireland

Tenovus Cancer Callback: With Welsh cancer patients every step of the way

Year:

Session type:

Louise Jenkins1, Dianne Harding1, Uta Preece1, Tara Day1, Jane Bridgeman1, Rachel Iredale1
1Tenovus, Cardiff, UK

Delivering Cancer Awareness with Liverpool Football Club Foundation Men’s Health Programme

Year:

Session type:

Ruth Stafferton1, Emma Squibb1, Christine Mounsey2, Mark Haig2, John Neoptolemos1
1Cancer Research UK Liverpool Centre, Liverpool, UK, 2Liverpool Football Club Foundation, Liverpool, UK

Recognition of cancer warning signs and anticipated time to help-seeking in a population sample of adults in the UK

Year:

Session type:

Samantha L Quaife1, Lindsay JL Forbes2, Amanda J Ramirez2, Kate E Brain3, Conan Donnelly4, Alice E Simon5, Jane Wardle1
1Health Behaviour Research Centre, University College London, London, UK, 2Promoting Early Presentation Group, King's College London, London, UK, 3Cochrane Institute of Primary Care and Public Health, Cardiff University, Cardiff, UK, 4Centre for Public Health, Queen's University Belfast, Belfast, UK, 5City University, London, UK

Dimensions of cancer fear in the screening context: a qualitative synthesis

Year:

Session type:

Charlotte Vrinten1, Georgia Black1, Lesley McGregor1, Malgorzata Heinrich1, Christian von Wagner1, Jo Waller1, Jane Wardle1
1University College London, London, UK

Circulating microRNAs as non-invasive biomarkers for breast cancer

Year:

Session type:

David Guttery1, Karen Page1, Lindsay Primrose1, Kevin Blighe1, Stephanie Marchese2, Allison Hills2, Laura Woodley2, Suzy Cleator2, Carlo Palmieri2, Justin Stebbing2, Charles Coombes2, Jacqui Shaw1, Joe Esland1
1University of Leicester, Leicester, UK, 2Imperial College, London, UK

The Cancer Drugs Fund and variation in cancer drug prescribing: England versus Wales

Year:

Session type:

Charlotte Chamberlain1, Pete Stephens2, Kate Tilling1, William Hollingworth1
1University of Bristol, Bristol, UK, 2IMS Health, London, UK

Extended adjuvant aromatase inhibition after 5 years of tamoxifen in women who were pre-menopausal at the time of diagnosis of early breast cancer.  Real time experience data.

Year:

Session type:

MH Ruhe Chowdhury1, Amanda Shewbridge1, Ines Sandri1, Sivanadiyan Kabilan1, Janine Mansi1
1Guy's and St Thomas' Hospital, London, UK

Individual funding requests and exceptionality: Does the Cancer Drugs Fund have anything to learn from PCTs?

Year:

Session type:

A Ford1
1Clatterbridge Cancer Centre, Merseyside, UK

Impact of a new acute oncology team (AOT) on quality of care and length of stay (LOS) of cancer patients admitted as an emergency to an acute (non-cancer) hospital

Year:

Session type:

Helen Neville-Webbe1,2, Michelle Roberts1, Sarah Cox1
1Southport and Ormskirk District General Hospital, Merseyside, UK, 2Clatterbridge Cancer Centre, Merseyside, UK

Prospective definition of a diagnostic algorithm for EML4-ALK gene fusions or surrogates in NSCLC in the routine diagnostic setting: The effect of several testing methodologies and sample types.

Year:

Session type:

Perry Maxwell1,2, Claire McGready2, Stephen McQuaid1,2, Neil Anderson1, Jacqueline James2, Manuel Salto Tellez2
1NI MPL, Belfast Health & Social Care Trust, Belfast, UK, 2NI MPL, Queen's University Belfast, Belfast, UK

Building on the 3 pillars of acute oncology: A snapshot audit 3 years on

Year:

Session type:

Adam Fullagar1, Antonia Creak1, Sarah Westwell1, Juliet Brock1
1Brighton and Sussex University Hospitals NHS Trust, Sussex, UK

Inequitable use of the Cancer Drug Fund (CDF) according to region of England and Primary Care Trust (PCT)

Year:

Session type:

James Clark1, Peter Jones2
1University of Cambridge School of Clinical Medicine, Cambridge, UK, 2Health Services Unit, Keele University, Keele, UK

A study into factors which influence breast cancer patients’ decision to accept chemotherapy

Year:

Session type:

Sophie Hancock1, Elaine Young2
1University of Manchester, Manchester, UK, 2Lancashire Teaching Hospitals NHS Trust, Lancashire, UK

Vaccination of chemotherapy patients – effect of guideline implementation

Year:

Session type:

Michelle Toleman1, Noel McCarthy2, David Church1
1Oxford Cancer Centre, Oxford, UK, 2Public Health England, Didcot, UK

NHS and industry partnership – an example of successful collaborative work

Year:

Session type:

Nancy Fernandes da Silva1, Zoe Stamataki1, Gillian Heap1, Angela Ball1
1The Christie NHS Foundation Trust, Manchester, UK

Patients as authors

Year:

Session type:

Christine Douglass1, Miriam Dwek1, Joram ten Brink1
1University of Westminster, London, UK

A Trans Network Collaborative Training Initiative

Year:

Session type:

Heather Phillips1, Julia Simister2, Charlotte Mahuma3, Alison Allen4, Emma Saunders5, Carrie Weller6, Gillian Ellis7
1Mount Vernon Cancer Research Network, Pan London & SE Region, UK, 2Surrey, West Sussex and Hampshire Cancer Research Network, Pan London & SE Region, UK, 3Essex and Hertfordshire Comprehensive Local Research Network, Essex and Hertfordshire, UK, 4Essex and Hertfordshire Comprehensive Local Research Network, Essex and Hertfordshire, UK, 5South London Comprehensive Local Clinical Research Network, South London, UK, 6The Royal Marsden NHS Foundation Trust, London, UK, 7NCRN Pan London and South East Regional Workforce Development Group, Pan London & SE Region, UK

PIK3CA Mutation Kit comparisons in FFPE breast cancer samples

Year:

Session type:

Pauline Kirk1, Amanda Davies1, James Sherwood1, Angela Dale1, Hedley Carr1, Jessica Whiteley1, Helen Ambrose1, Mark Hampson1
1AstraZeneca, Macclesfield, UK

Factors affecting uptake of bowel screening

Year:

Session type:

Patricia Gunning1, Frank Dunstan1, Ronan Lyons2, Rosemary Fox3
1Cardiff University, Cardiff, UK, 2Swansea University, Swansea, UK, 3Public Health Wales, Cardiff, UK

RESECT: A supportive care pathway for liver REsection following downSizing with chEmotherapy plus Cetuximab in meTastatic colorectal cancer in UK NHS practice

Year:

Session type:

Hassan Malik1, Amanda Pulfer2, Michael Thompson3
1University Hospital Aintree NHS Trust, Liverpool, UK, 2pH Associates Ltd, Marlow, UK, 3Merck Serono Ltd, Feltham, UK

Evaluating the impact of a new consultant ward round

Year:

Session type:

Vishal Navani1, David Bloomfield1, Ghomaissa Rosie1, Reshma Ghedia1
1Brighton and Sussex University Hospitals, Brighton, UK

30-day mortality after systemic anti-cancer therapy (SACT) – Using and evaluating the NCEPOD audit toolkit

Year:

Session type:

Alison Berner1, Mahalakshmi Mohan1, Ian Grant1
1Barking, Havering & Redbridge University Hospitals NHS Trust, London, UK

Is it feasible to follow-up testicular germ-cell tumour patients in Sussex via the telephone?

Year:

Session type:

Emma Campbell1,2, Duncan Gilbert2,1, David Bloomfield2,1
1Brighton and Sussex Medical School, Brighton, UK, 2Royal Sussex County Hospital, Brighton, UK

Incidence screening inequalities in the NHS Bowel Cancer Screening Programme

Year:

Session type:

Siu Hing Lo1, Christian von Wagner1, Julia Snowball2, Stephen Halloran2,3, Jane Wardle1
1University College London, London, UK, 2Bowel Cancer Screening Programme, Southern Hub, Royal Surrey County Hospital, Surrey, UK, 3University of Surrey, Surrey, UK

TLR2 and TLR4 polymorphisms, gene and protein expression in risk of sporadic colorectal cancer

Year:

Session type:

Marcela Alcântara Proença1, Aline Cristina Targa Cadamuro1, Juliana Garcia Oliveira5, Patrícia Matos Biselli Chicote2, Joice Matos Biselli1, Katia Ramos Moreira Leite4, Geni Satomi Cunrath3, João Gomes Netinho3, Érika Cristina Pavarino2, Eny Maria Goloni Bertollo2, Ana Elizabete Silva1
1UNESP – São Paulo State University, São José do Rio Preto, Brazil, 2FAMERP – São José do Rio Preto Medical School, São José do Rio Preto, Brazil, 3Base Hospital, São José do Rio Preto, Brazil, 4Sírio Libanês Hospital, São José do Rio Preto, Brazil, 5USC - Universidade do Sagrado Coração, Bauru, Brazil

Mismatch between cancer symptom knowledge and symptom attribution in daily life: A population-based study

Year:

Session type:

Katriina Whitaker1, Una Macleod3, Alice Simon4, Suzanne Scott2, Jane Wardle1
1University College London, London, UK, 2King's College London, London, UK, 3Hull York Medical School, Hull, UK, 4City University, London, UK

Segmenting the 2 million – new understanding of people living with cancer

Year:

Session type:

Lucy Irvine1, Hannah McConnell2
(NCIN) National Cancer Intelligence Network, 2Macmillan Cancer Support, London, UK

Could deprivation account for the relatively good recruitment from the west of Scotland into NCRN Testis Clinical Studies Group poor prognosis trials?

Year:

Session type:

Cicely Cunningham1, Sharon Armstrong2, Ashita Waterston1, Nicola Thomson1, David Morrison1, Jeff White1
1The Beatson West of Scotland Cancer Centre, Glasgow, UK, 2Tayside Canccer Centre, Ninewells Hospital, Dundee, UK

Skin cancer knowledge and sun protection behaviours in medical and non-medical university students in Karachi, Pakistan

Year:

Session type:

Rafaqat Bota1
1Dow Medical College, Karachi, Pakistan

How much of the deprivation gap in cancer survival can be explained by variation in stage at diagnosis: An example from breast cancer in the East of England

Year:

Session type:

Gary Abel1, Mark Rutherford2, Sally Hinchliffe2, Georgios Lyratzopoulos1, Paul Lambert2,3, David Greenberg4,1
1University of Cambridge, Cambridge, UK, 2University of Leicester, Leicester, UK, 3Karolinska Institutet, Stockholm, Sweden, 4National Cancer Registration Service, Public Health England, Eastern Office, Cambridge, UK

Evaluation of outcomes in counselling for cancer patients and families across Wales

Year:

Session type:

Helen French1, Sioned Pearce1, Rachel Iredale1
1Tenovus, Cardiff, UK

Telomere length shows no association with BRCA1 and BRCA2 mutation status

Year:

Session type:

M Tymrakiewicz1, E Killick1, C Cieza-Borrella2, P Smith3, DJ Thompson3, KA Pooley3, E Bancroft4, E Page1, Z Kote-Jarai1, RA Eeles1
1The Institute of Cancer Research, London, UK, 2Universidad de Salamanca, Salamanca, Spain, 3University of Cambridge, Cambridge, UK, 4The Royal Marsden Hospital NHS Trust, London, UK

Introducing a balanced scorecard approach to monitoring the quality and performance of National Cancer Research Network (NCRN) education and training events in the northern region of England

Year:

Session type:

Robyn Peary1, Steve Glover1
1The Christie School of Oncology, Manchester, UK

Human tissue validation of potential biomarkers for colorectal cancer

Year:

Session type:

Shahram Ibrahim1, Karen Reed2, Abeer Hammoudi1, Alan Clarke2, Mark Pritchard1, John Jenkins1
1University of Liverpool, Liverpool, UK, 2University of Cardiff, Cardiff, UK